Buscar
LakeShore Biopharma Co Ltd
LSBAñadir a la lista de seguimiento
0.627USD
0.0000.00%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
13.02MCap. mercado
--P/E TTM
Más Datos de LakeShore Biopharma Co Ltd Compañía
LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
Información de LakeShore Biopharma Co Ltd
Símbolo de cotizaciónLSB
Nombre de la empresaLakeShore Biopharma Co Ltd
Fecha de salida a bolsaJul 30, 2021
Director ejecutivoMr. Dave Chenn
Número de empleados573
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 30
DirecciónBuilding No. 2, 38 Yongda Road
CiudadBEIJING
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísChina
Código postal102629
Teléfono
Sitio Webhttps://www.ysbiopharm.com/
Símbolo de cotizaciónLSB
Fecha de salida a bolsaJul 30, 2021
Director ejecutivoMr. Dave Chenn
Ejecutivos de LakeShore Biopharma Co Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
Mr. Gang Li
Mr. Gang Li
Head of Marketing and sales
Head of Marketing and sales
--
--
Dr. Stanley Yi Chang
Dr. Stanley Yi Chang
Independent Director
Independent Director
--
--
Dr. Ajit Shetty
Dr. Ajit Shetty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Thomas Xue
Mr. Thomas Xue
Director
Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de LakeShore Biopharma Co Ltd?
Los cinco principales accionistas de LakeShore Biopharma Co Ltd son: Mr. Yi Zhang
¿Cuántas instituciones poseen acciones de LakeShore Biopharma Co Ltd (LSB)?
A fecha de 2026Q1, 18 instituciones poseen acciones de LakeShore Biopharma Co Ltd, con un valor de mercado combinado de aproximadamente 606.46K, lo que representa el 1.47% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -1434782.00.